COPD Clinical Trial
Official title:
Sustainability of Rehabilitation Gains in COPD
People with moderate to severe COPD trap air in their lungs. This lessens their ability to exercise. The investigators developed a computerized breathing retraining program to help patients empty their lungs during exercise. The investigators believe that learning to control breathing will help patients be more active. The purpose of this study is to test the effects of using breathing retraining (intervention group) versus no breathing retraining (control group) as part of a 12-week exercise program. The investigators are examining the long term effects of this training on exercise capacity and the ability to empty ones lungs during exercise. Patients will participate in a 12-week exercise program, with or without breathing retraining. They will then participate in a 42 week adherence program to maintain physical activity. Patient testing will be competed at baseline, 12 weeks, 6 months and 1 year. 250 patients with moderate to severe COPD will be enrolled.
Rationale: Development of dynamic hyperinflation is a primary limiting factor of exercise
tolerance in chronic obstructive pulmonary disease (COPD). To lessen the development of
dynamic hyperinflation, and to improve exercise tolerance in COPD patients, the investigators
have developed a breathing-retraining technique to be used during pulmonary rehabilitation.
This breathing-retraining technique is designed to decrease respiratory rate and prolong
exhalation. The investigators demonstrated that, in the short-term, hyperinflation and
exercise duration improved more with breathing-retraining plus exercise-training than with
exercise-training alone. Because a crucial aspect of pulmonary rehabilitation is the
maintenance its short-term benefits over the long-term, the investigators now propose to test
whether short-term benefits of breathing-retraining plus exercise followed by an
adherence-intervention program are sustainable over the long-term Primary Hypothesis: (H1) In
COPD patients, improvements in exercise duration on a constant- load treadmill test will be
greater after 12 weeks of breathing-retraining plus exercise-training followed by a 42-week
adherence-intervention program (1 yr. total) than after 12 weeks of exercise-training alone
followed by a 42-week adherence-intervention program (1 yr. total). Secondary Hypotheses: One
year after randomization, exercise-induced dynamic hyperinflation will be less during a
constant-load treadmill test (H2), 6-minute walking distance will be longer (H3), and mastery
over breathing will be greater (H4) in the breathing-retraining plus exercise-training group
than in the exercise-alone group. Lastly (exploratory objective), the investigators will
assess the effect of the patient's physiologic, psychologic and clinical phenotype on short-
term and long-term responsiveness to pulmonary rehabilitation.
Methods: The proposed study is a randomized, controlled clinical trial in which 250 patients
with moderate-to-severe COPD will be enrolled. One hundred forty of these patients are
expected to qualify for randomization into the breathing-retraining plus exercise-training
group or the exercise-training alone group. Patients will receive 12-weeks of supervised
training according to group assignment (three times weekly) followed by an
adherence-intervention program (weekly phone motivational interviews, home-exercise program,
and monthly laboratory booster sessions). Follow-up testing will be completed at 12 weeks,
and at 6 and 12 months. Testing will include pulmonary function test, incremental-load and
constant-load treadmill tests, 6-minute walk test, measurements of dyspnea, assessment of
respiratory and quadriceps muscle strength and endurance and quadriceps ultrasonography.
Analysis: In the principal analysis of the primary outcome measure (exercise duration; H1)
the investigators will compare changes in exercise duration (constant work-rate treadmill
test) from baseline to end of study using 2-sample t-test (two-tailed =.05). The primary
analysis will be based on intention-to-treat principles. Multiple imputation will be used for
study subjects missing the 12-month measurement. This imputation model will be based on
baseline characteristics of study participants. Several secondary analyses of the primary
outcome measure will be performed (H2-H4). Linear regression will be used to determine
whether the observed treatment benefits persist after adjustment for baseline covariates and
measures of adherence to treatment. Since several measurements will be taken on each patient,
mixed-models analysis will be used to compare the changes on the constant-load treadmill test
over time between the two groups.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06000696 -
Healthy at Home Pilot
|
||
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
| Completed |
NCT04105075 -
COPD in Obese Patients
|
||
| Recruiting |
NCT05825261 -
Exploring Novel Biomarkers for Emphysema Detection
|
||
| Active, not recruiting |
NCT04075331 -
Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial
|
Phase 2/Phase 3 | |
| Terminated |
NCT03640260 -
Respiratory Regulation With Biofeedback in COPD
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|
||
| Withdrawn |
NCT04210050 -
Sleep Ventilation for Patients With Advanced Hypercapnic COPD
|
N/A | |
| Terminated |
NCT03284203 -
Feasibility of At-Home Handheld Spirometry
|
N/A | |
| Recruiting |
NCT06110403 -
Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT06040424 -
Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
|
Phase 3 | |
| Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
| Recruiting |
NCT04868357 -
Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program
|
N/A | |
| Completed |
NCT01892566 -
Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV
|
N/A | |
| Completed |
NCT04119856 -
Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD
|
N/A | |
| Completed |
NCT04485741 -
Strados System at Center of Excellence
|
||
| Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
| Recruiting |
NCT04860375 -
Multidisciplinary Management of Severe COPD
|
N/A |